Spark Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
18 Dec 2019	Form 3: Roche Holdings Inc, 10% owner and 1 other Holds 29,746,673 shares of Common Stock
23 Feb 2018	Form 3: Mingozzi Federico, Chief Scientific Officer
23 Feb 2018	Form 3: Dalton Lisa, Head of Human Resources Holds 1,385 shares of Common Stock
04 Jan 2018	Form 3: Perez Robert J, Director No securities owned
05 Dec 2016	Form 3: Furey John, Chief Operating Officer No securities owned
04 May 2016	Form 3: La Barge Joseph, See remarks Holds 5,325 shares of Common Stock
04 May 2016	Form 3: Faga Daniel, Chief Business Officer No securities owned
08 Jan 2016	Form 3: Zoth Lota S., Director No securities owned
29 Jan 2015	Form 3: Mehra Anand, Director and 5 others
29 Jan 2015	Form 3: High Katherine A, Director Holds 340,000 shares of Common Stock
29 Jan 2015	Form 3: Marrazzo Jeffrey D, Director Holds 380,000 shares of Common Stock
29 Jan 2015	Form 3: Vivaldi Coelho Rogerio, Chief Commercial Officer Holds 3,883 shares of Common Stock
29 Jan 2015	Form 3: Sigal Elliot, Director Holds 6,214 shares of Common Stock
29 Jan 2015	Form 3: Milano Vincent, Director
29 Jan 2015	Form 3: Webster Stephen W, Chief Financial Officer
29 Jan 2015	Form 3: Ekman Lars, Director
29 Jan 2015	Form 3: Betz Alert Lorris, Director Holds 0 shares of No securities are beneficially owned
29 Jan 2015	Form 3: Altschuler Steven, Director
29 Jan 2015	Form 3: Children's Hospital of Philadelphia Foundation, 10% owner Holds 4,943,629 shares of Common Stock

Comments